HF
TEVA icon

HRT Financial’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

HRT Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
319,400
+91,900
+40% +$3.06M 0.02% 740
2026
Q1 		$6.85M Buy
+227,500
New +$7.32M 0.02% 812
2020
Q2 		– Sell
-23,900
Closed -$214K – 1753
2020
Q1 		$214K Buy
+23,900
New +$245K 0.01% 562
2019
Q2 		– Sell
-14,800
Closed -$232K – 911
2019
Q1 		$232K Buy
+14,800
New +$261K 0.04% 354

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

HRT Financial's TEVA Position: Q2 2026 in Review

HRT Financial increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 111% in Q2 2026, buying an estimated $5.19M and bringing the position to 295,918 shares worth $10M. The position accounts for 0.02% of the portfolio, ranked #780.

HRT Financial first reported a position in TEVA in Q4 2018 and has held it in 14 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • HRT Financial held 295,918 shares of Teva Pharmaceutical Industries Limited worth $10M as of Q2 2026.
  • HRT Financial bought 155,696 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $5.19M.
  • Teva Pharmaceutical Industries Limited made up 0.02% of HRT Financial's portfolio in Q2 2026, its #780 holding.
  • HRT Financial first reported a position in Teva Pharmaceutical Industries Limited in Q4 2018 and has held it in 14 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.